{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:06:24Z","timestamp":1791864384124,"version":"4.3.4"},"reference-count":49,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,2,15]]},"DOI":"10.18632\/aging.203882","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T17:43:47Z","timestamp":1644601427000},"page":"1200-1213","source":"Crossref","is-referenced-by-count":13,"title":["Binding of the angiogenic\/senescence inducer CCN1\/CYR61 to integrin \u03b16\u03b21 drives endocrine resistance in breast cancer cells"],"prefix":"10.18632","volume":"14","author":[{"given":"Ingrid","family":"Espinoza","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, 55905 MN, USA"},{"name":"Current address: Department of Preventive Medicine, John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS 39216, USA"},{"name":"Current address: Cancer Institute, School of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, 55905 MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis Vander","family":"Steen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, 55905 MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Vellon","sequence":"additional","affiliation":[{"name":"Stem Cells Laboratory, Institute of Biology and Experimental Medicine (IBYME-CONICET), Buenos Aires C1428ADN, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Cuy\u00e0s","sequence":"additional","affiliation":[{"name":"Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona 17005, Spain"},{"name":"Girona Biomedical Research Institute, Salt, Girona 17190, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Verdura","sequence":"additional","affiliation":[{"name":"Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona 17005, Spain"},{"name":"Girona Biomedical Research Institute, Salt, Girona 17190, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Genetics, College of Medicine, The University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier A.","family":"Menendez","sequence":"additional","affiliation":[{"name":"Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona 17005, Spain"},{"name":"Girona Biomedical Research Institute, Salt, Girona 17190, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Lupu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, 55905 MN, USA"},{"name":"Department of Biochemistry and Molecular Biology Laboratory, Mayo Clinic Minnesota, Rochester, MN 55905, USA"},{"name":"Mayo Clinic Cancer Center, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0140-6736(03)15172-0","article-title":"CCN proteins: multifunctional signalling regulators.","volume":"36","author":"Perbal","year":"2004","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2741\/1594","article-title":"CCN proteins and cancer: two to tango.","volume":"1","author":"Perbal","year":"2005","journal-title":"Front Biosci"},{"key":"3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tibs.2008.07.006","article-title":"The CCN family of proteins: structure-function relationships.","volume":"3","author":"Perbal","year":"2008","journal-title":"Trends Biochem Sci"},{"key":"4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12079-018-0455-5","article-title":"The concept of the CCN protein family revisited: a centralized coordination network.","volume":"1","author":"Perbal","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"5","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1128\/mcb.10.7.3569-3577.1990","article-title":"Expression of cyr61, a growth factor-inducible immediate-early gene.","volume":"1","author":"Lau","year":"1990","journal-title":"Mol Cell Biol"},{"key":"6","first-page":"645","article-title":"Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development.","volume":"3","author":"Lau","year":"1992","journal-title":"Cell Growth Differ"},{"key":"7","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1128\/MCB.16.4.1326","article-title":"Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion.","volume":"1","author":"Lau","year":"1996","journal-title":"Mol Cell Biol"},{"key":"8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1006\/dbio.1997.8766","article-title":"Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells.","volume":"19","author":"Lau","year":"1997","journal-title":"Dev Biol"},{"key":"9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1006\/excr.1997.3548","article-title":"Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development.","volume":"23","author":"Lau","year":"1997","journal-title":"Exp Cell Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/sj.onc.1201572","article-title":"Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells.","volume":"1","author":"Lau","year":"1998","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ncb2070","article-title":"The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing.","volume":"1","author":"Lau","year":"2010","journal-title":"Nat Cell Biol"},{"key":"12","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1128\/MCB.00049-13","article-title":"Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.","volume":"3","author":"Lau","year":"2013","journal-title":"Mol Cell Biol"},{"key":"13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.18632\/aging.100201","article-title":"Cellular senescence controls fibrosis in wound healing.","volume":"2","author":"Lau","year":"2010","journal-title":"Aging (Albany NY)"},{"key":"14","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1073\/pnas.95.11.6355","article-title":"CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.","volume":"9","author":"Lau","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"15","first-page":"5603","article-title":"Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies.","volume":"6","author":"Lupu","year":"2000","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"8178","DOI":"10.1038\/sj.onc.1205682","article-title":"Cyr61 promotes breast tumorigenesis and cancer progression.","volume":"2","author":"Lupu","year":"2002","journal-title":"Oncogene"},{"key":"17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1677\/erc.0.0100141","article-title":"The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.","volume":"1","author":"Lupu","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"18","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-05-0231","article-title":"Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.","volume":"1","author":"Koeffler","year":"2005","journal-title":"Clin Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ygyno.2008.09.039","article-title":"Cyr61, a member of ccn (connective tissue growth factor\/cysteine-rich 61\/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.","volume":"11","author":"Sakuragi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"9200","DOI":"10.18632\/oncotarget.13677","article-title":"The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.","volume":"8","author":"R\u00fcegg","year":"2017","journal-title":"Oncotarget"},{"key":"21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/excr.1999.4456","article-title":"The CCN family of angiogenic regulators: the integrin connection.","volume":"24","author":"Lam","year":"1999","journal-title":"Exp Cell Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12079-016-0324-z","article-title":"Cell surface receptors for CCN proteins.","volume":"1","author":"Lau","year":"2016","journal-title":"J Cell Commun Signal"},{"key":"23","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s00018-011-0778-3","article-title":"CCN1\/CYR61: the very model of a modern matricellular protein.","volume":"6","author":"Lau","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12079-018-0450-x","article-title":"The matricellular protein CCN1 in tissue injury repair.","volume":"1","author":"Lau","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"25","doi-asserted-by":"publisher","first-page":"21943","DOI":"10.1074\/jbc.M100978200","article-title":"CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain.","volume":"27","author":"Lau","year":"2001","journal-title":"J Biol Chem"},{"key":"26","doi-asserted-by":"publisher","first-page":"33801","DOI":"10.1074\/jbc.M305862200","article-title":"Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61).","volume":"27","author":"Lau","year":"2003","journal-title":"J Biol Chem"},{"key":"27","doi-asserted-by":"publisher","first-page":"44166","DOI":"10.1074\/jbc.M406813200","article-title":"Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells.","volume":"27","author":"Lau","year":"2004","journal-title":"J Biol Chem"},{"key":"28","doi-asserted-by":"publisher","first-page":"44177","DOI":"10.1074\/jbc.M407850200","article-title":"Targeted mutagenesis of the angiogenic protein CCN1 (CYR61). Selective inactivation of integrin alpha6beta1-heparan sulfate proteoglycan coreceptor-mediated cellular functions.","volume":"27","author":"Lau","year":"2004","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"publisher","first-page":"14187","DOI":"10.1074\/jbc.M009755200","article-title":"Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.","volume":"27","author":"Koeffler","year":"2001","journal-title":"J Biol Chem"},{"key":"30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.onc.1208238","article-title":"A novel CYR61-triggered \u2018CYR61-alphavbeta3 integrin loop\u2019 regulates breast cancer cell survival and chemosensitivity through activation of ERK1\/ERK2 MAPK signaling pathway.","volume":"2","author":"Lupu","year":"2005","journal-title":"Oncogene"},{"key":"31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.18632\/oncoscience.314","article-title":"The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells.","volume":"3","author":"Lupu","year":"2016","journal-title":"Oncoscience"},{"key":"32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2174\/1568009616666160426125058","article-title":"CYR61 Confers the Sensitivity to Aromatase Inhibitor Letrozole in ER Positive Breast Carcinoma.","volume":"1","author":"Shao","year":"2017","journal-title":"Curr Cancer Drug Targets"},{"key":"33","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3892\/ol.2017.6406","article-title":"Clinical relevance of Cyr61 expression in patients with hormone-dependent breast cancer.","volume":"1","author":"Hirschfeld","year":"2017","journal-title":"Oncol Lett"},{"key":"34","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1038\/sj.onc.1208452","article-title":"AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.","volume":"2","author":"Lupu","year":"2005","journal-title":"Oncogene"},{"key":"35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/mc.20242","article-title":"A bidirectional \u201calpha(v)beta(3) integrin-ERK1\/ERK2 MAPK\u201d connection regulates the proliferation of breast cancer cells.","volume":"4","author":"Lupu","year":"2006","journal-title":"Mol Carcinog"},{"key":"36","doi-asserted-by":"publisher","first-page":"C1524","DOI":"10.1152\/ajpcell.2001.281.5.C1524","article-title":"Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways.","volume":"28","author":"Chaqour","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF02256579","article-title":"Organization and expression of the Cyr61 gene in normal human fibroblasts.","volume":"9","author":"Sadowski","year":"2002","journal-title":"J Biomed Sci"},{"key":"38","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1128\/MCB.01316-10","article-title":"CCN5, a novel transcriptional repressor of the transforming growth factor \u03b2 signaling pathway.","volume":"3","author":"Redeuilh","year":"2011","journal-title":"Mol Cell Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molonc.2007.02.004","article-title":"The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.","volume":"1","author":"Bissell","year":"2007","journal-title":"Mol Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"e59689","DOI":"10.1371\/journal.pone.0059689","article-title":"Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines.","volume":"8","author":"Stoecklein","year":"2013","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12079-013-0214-6","article-title":"CCN1 promotes vascular endothelial growth factor secretion through \u03b1v\u03b2 3 integrin receptors in breast cancer.","volume":"8","author":"Lupu","year":"2014","journal-title":"J Cell Commun Signal"},{"key":"42","doi-asserted-by":"publisher","first-page":"39097","DOI":"10.18632\/oncotarget.9772","article-title":"Estrogen receptor alpha inhibits senescence-like phenotype and facilitates transformation induced by oncogenic ras in human mammary epithelial cells.","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.lfs.2013.12.009","article-title":"Premature senescence in human breast cancer and colon cancer cells by tamoxifen-mediated reactive oxygen species generation.","volume":"9","author":"Bae","year":"2014","journal-title":"Life Sci"},{"key":"44","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/sj.emboj.7601596","article-title":"Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling.","volume":"2","author":"Lau","year":"2007","journal-title":"EMBO J"},{"key":"45","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/978-1-4419-6612-4_63","article-title":"The extracellular matrix protein CCN1 dictates TNF\u03b1 and FasL cytotoxicity","volume":"69","author":"Lau","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"46","doi-asserted-by":"publisher","first-page":"e31303","DOI":"10.1371\/journal.pone.0031303","article-title":"TNF\u03b1-induced apoptosis enabled by CCN1\/CYR61: pathways of reactive oxygen species generation and cytochrome c release.","volume":"7","author":"Lau","year":"2012","journal-title":"PLoS One"},{"key":"47","doi-asserted-by":"publisher","first-page":"e20028","DOI":"10.1371\/journal.pone.0020028","article-title":"Suppression of estrogen receptor transcriptional activity by connective tissue growth factor.","volume":"6","author":"Ye","year":"2011","journal-title":"PLoS One"},{"key":"48","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1161\/CIRCULATIONAHA.119.039530","article-title":"CCN1-Induced Cellular Senescence Promotes Heart Regeneration.","volume":"13","author":"Zhang","year":"2019","journal-title":"Circulation"},{"key":"49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-1-60761-913-0_14","article-title":"Purification of proteins fused to glutathione S-transferase.","volume":"68","author":"Speicher","year":"2011","journal-title":"Methods Mol Biol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:36:42Z","timestamp":1645461402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,2,15]]}},"alternative-id":["203882","35148282"],"URL":"https:\/\/doi.org\/10.18632\/aging.203882","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]}}}